Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem.
Kunzler AM, Iannizzi C, Burns J, Metzendorf MI, Voigt-Radloff S, Piechotta V, Schmaderer C, Holzmann-Littig C, Balzer F, Benstoem C, Binder H, Boeker M, Dirnagl U, Fichtner F, Golinski M, Grundmann H, Hengel H, Jabs J, Kern WV, Kopp I, Kranke P, Kreuzberger N, Laudi S, Lichtner G, Lieb K, Maun A, Moerer O, Müller A, Mutters NT, Nothacker M, Pfadenhauer LM, Popp M, Rüschemeyer G, Schmucker C, Schwingshackl L, Spies C, Steckelberg A, Stegemann M, Strech D, von Dincklage F, Weibel S, Wunderlich MM, Zöller D, Rehfuess E, Skoetz N, Meerpohl JJ; CEOsys Consortium. Kunzler AM, et al. Among authors: piechotta v. J Clin Epidemiol. 2024 Sep;173:111456. doi: 10.1016/j.jclinepi.2024.111456. Epub 2024 Jul 14. J Clin Epidemiol. 2024. PMID: 39002765 Free article.
[Development of criteria for the prospective assessment of the need for updating guideline recommendations: The AGIL criteria].
Siemens W, Mahler S, Schaefer C, Nothacker M, Piechotta V, Prien P, Schüler S, Schwarz S, Blödt S, Thielemann I, Harder T, Kapp P, Labonté V, Meerpohl JJ, Braun C. Siemens W, et al. Among authors: piechotta v. Z Evid Fortbild Qual Gesundhwes. 2024 Mar;184:7-17. doi: 10.1016/j.zefq.2023.11.006. Epub 2024 Jan 18. Z Evid Fortbild Qual Gesundhwes. 2024. PMID: 38238131 Free article. German.
Remdesivir for the treatment of COVID-19: a Cochrane review.
Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Ansems K, et al. Among authors: piechotta v. Emergencias. 2023 Dec;35(6):465-467. doi: 10.55633/s3me/E012.2023. Emergencias. 2023. PMID: 38116972 Review. English, Spanish. No abstract available.
Colchicine for the treatment of COVID-19.
Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Mikolajewska A, et al. Among authors: piechotta v. Emergencias. 2023 Aug;35(4):300-302. doi: 10.55633/s3me/E046.2023. Emergencias. 2023. PMID: 37439424 English, Spanish. No abstract available.
43 results